SCHEMBL28894841

SCHEMBL28894841

CCOC(=O)c1c([N+](=O)[O-])c(C)nn1Cc1ccc(OC)cc1

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.56
NPC1 O15118 1/20 0.56
ALDH1A1 P00352 5/20 0.51
KDM4E B2RXH2 2/20 0.51
MAPK1 P28482 2/20 0.51
UCHL1 P09936 1/20 0.51
LMNA P02545 1/20 0.51
HTT P42858 1/20 0.51
TDP1 Q9NUW8 1/20 0.51
L3MBTL1 Q9Y468 1/20 0.51
MAPT P10636 4/20 0.47
GAA P10253 1/20 0.45
SMN1; SMN2 Q16637 2/20 0.44
PDE4D Q08499 2/20 0.44
KMT2A Q03164 1/20 0.43
PDE4A P27815 1/20 0.43
PDE4B Q07343 1/20 0.43
PDE4C Q08493 1/20 0.43
DCTPP1 Q9H773 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14124978 0.87 MAPK1 (0.57) RAB9ANPC1ALDH1A1MAPK1LMNA
SCHEMBL23486567 0.82 PDE4D (0.55) RAB9ANPC1ALDH1A1KDM4EMAPK1
SCHEMBL22609338 0.81 UCHL1 (0.54) NPC1ALDH1A1KDM4EMAPK1UCHL1
SCHEMBL16832564 0.81 RAB9A (0.77) RAB9ANPC1ALDH1A1KDM4EMAPK1
SCHEMBL25397001 0.81 MEN1 (0.50) RAB9ANPC1ALDH1A1KDM4EMAPK1
SCHEMBL19762437 0.80 RAB9A (0.61) RAB9ANPC1ALDH1A1KDM4EMAPK1
SCHEMBL28432522 0.79 ALDH1A1 (0.57) NPC1ALDH1A1LMNAHTTL3MBTL1
Hexane SCHEMBL23453729 0.79 PDE4D (0.52) RAB9ANPC1ALDH1A1KDM4EMAPK1
SCHEMBL3800033 0.77 UCHL1 (0.54) ALDH1A1KDM4EMAPK1UCHL1HTT
SCHEMBL4221650 0.76 UCHL1 (0.56) ALDH1A1KDM4EMAPK1UCHL1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115403584-B 2-thio-2, 3-dihydropyrimidine-4-one derivatives, pharmaceutical compositions, preparation methods and applications thereof 长春金赛药业有限责任公司 2024-04-02 CN disclosed
CN-111556871-B 1H-pyrazolo [4,3-b ] pyridines as PDE1 inhibitors H.隆德贝克有限公司 2023-07-07 CN disclosed
CN-111491936-B Macrocyclic compounds as PDE1 inhibitors H.隆德贝克有限公司 2023-07-04 CN disclosed
CN-115403584-A 2-thio-2, 3-dihydropyrimidine-4-one derivative, pharmaceutical composition, preparation method and application thereof 长春金赛药业有限责任公司 2022-11-29 CN disclosed
CN-111465410-B Combination therapy comprising administration of 1H-pyrazolo [4,3-B ] pyridine H.隆德贝克有限公司 2022-10-25 CN disclosed
CN-111526890-B Combination therapy comprising administration of 1H-pyrazolo [4,3-B ] pyridine H.隆德贝克有限公司 2022-10-14 CN disclosed